Correction to Lancet Infect Dis 2020; published online July 17. https://doi.org/10.1016/S1473-3099(20)30274-7

No authors listed

Published Erratum

No authors listed. Lancet Infect Dis. 2020 Sep.

. 2020 Sep;20(9):e215.

doi: 10.1016/S1473-3099(20)30628-9. Epub 2020 Jul 30.

No abstract available

Erratum for

Safety and immunogenicity of the live attenuated intranasal pertussis vaccine BPZE1: a phase 1b, double-blind, randomised, placebo-controlled dose-escalation study.
Jahnmatz M, Richert L, Al-Tawil N, Storsaeter J, Colin C, Bauduin C, Thalen M, Solovay K, Rubin K, Mielcarek N, Thorstensson R, Locht C; BPZE1 study team. Jahnmatz M, et al. Lancet Infect Dis. 2020 Nov;20(11):1290-1301. doi: 10.1016/S1473-3099(20)30274-7. Epub 2020 Jul 17. Lancet Infect Dis. 2020. PMID: 32687804 Clinical Trial.